Literature DB >> 25911567

Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.

Zorica Špirić1, Živka Eri2, Mirela Erić2.   

Abstract

INTRODUCTION: Induction of tumor lymphangiogenesis by vascular endothelial growth factor (VEGF)-C and VEGF-D promotes metastasis in many human cancers. AIM: The aim of this study was to examine the role of VEGF-C and VEGF-D in lymphangiogenesis and lymph node metastasis in patients with cutaneous melanoma.
MATERIALS AND METHODS: Fifty-four melanoma specimens (18 with lymph node metastasis, 36 nonmetastatic) were investigated by immunostaining for VEGF-C, VEGF-D, and for lymphatic endothelial marker D2-40. VEGF-C and VEGF-D expression was assessed as a percentage and intensity of stained tumor cells, tumor-associated macrophages and fibroblasts. The quantification of lymphangiogenesis was conducted by computer-assisted morphometric analysis.
RESULTS: The expressions of both VEGF-C and VEGF-D in tumor cells were significantly higher in lymph node metastatic melanomas compared with nonmetastatic melanomas (P = .015 VEGF-C; P = .005 VEGF-D). There was no statistically significant difference between metastatic and nonmetastatic melanomas regarding the expression of VEGF-C and VEGF-D in macrophages and fibroblasts. Metastatic melanomas showed a significantly higher intratumoral and peritumoral lymphatic vessel density (LVD) compared with nonmetastatic melanomas (P = .000 intratumoral, P = .000 peritumoral). Melanomas with VEGF-C positive tumor cells showed a significantly higher intratumoral and peritumoral LVD compared with VEGF-C negative tumor cells group of melanomas (P = .006 intratumoral, P = .010 peritumoral). VEGF-C expression in macrophages, fibroblasts, as well as VEGF-D expression in tumor cells, macrophages, and fibroblasts, showed no correlation with the intratumoral and peritumoral LVD.
CONCLUSIONS: Our findings show the significance of VEGF-C in tumor cells in the induction of intratumoral and peritumoral lymphangiogenesis. This study suggests that both VEGF-C and VEGF-D in tumor cells promote lymph node metastasis, and that the immunohistochemical analysis of expression can be a useful tool for predicting clinical behavior of cutaneous melanoma.
© The Author(s) 2015.

Entities:  

Keywords:  VEGF-C; VEGF-D; lymph node metastasis; lymphangiogenesis; melanoma

Mesh:

Substances:

Year:  2015        PMID: 25911567     DOI: 10.1177/1066896915583694

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  7 in total

1.  Effect of tumor-associated macrophages on gastric cancer stem cell in omental milky spots and lymph node micrometastasis.

Authors:  Chi Zhang; Xiang Hu; Xiao-Yu Liu; Pin Liang; Jian Zhang; Liang Cao; Zheng-Lin Wang; Huan-Ran Liu; Xun-Guo Yin; Cheng-Yong Dong; Li-Ming Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 2.  New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.

Authors:  Qiujun Guo; Zhichao Jin; Yuan Yuan; Rui Liu; Tao Xu; Huamin Wei; Xinyao Xu; Shulin He; Shuntai Chen; Zhan Shi; Wei Hou; Baojin Hua
Journal:  J Immunol Res       Date:  2016-11-16       Impact factor: 4.818

Review 3.  Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.

Authors:  Adriana Albini; Antonino Bruno; Douglas M Noonan; Lorenzo Mortara
Journal:  Front Immunol       Date:  2018-04-05       Impact factor: 7.561

4.  Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.

Authors:  Ana Carolina Monteiro; Julienne K Muenzner; Fernando Andrade; Flávia Eichemberger Rius; Christian Ostalecki; Carol I Geppert; Abbas Agaimy; Arndt Hartmann; André Fujita; Regine Schneider-Stock; Miriam Galvonas Jasiulionis
Journal:  Mol Oncol       Date:  2019-05-25       Impact factor: 6.603

Review 5.  Tumor angiogenesis: causes, consequences, challenges and opportunities.

Authors:  Roberta Lugano; Mohanraj Ramachandran; Anna Dimberg
Journal:  Cell Mol Life Sci       Date:  2019-11-06       Impact factor: 9.261

6.  Targeting macrophages in cancer immunotherapy.

Authors:  Zhaojun Duan; Yunping Luo
Journal:  Signal Transduct Target Ther       Date:  2021-03-26

7.  VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.

Authors:  Signe R Michaelsen; Mikkel Staberg; Henriette Pedersen; Kamilla E Jensen; Wiktor Majewski; Helle Broholm; Mette K Nedergaard; Christopher Meulengracht; Thomas Urup; Mette Villingshøj; Slávka Lukacova; Jane Skjøth-Rasmussen; Jannick Brennum; Andreas Kjær; Ulrik Lassen; Marie-Thérése Stockhausen; Hans S Poulsen; Petra Hamerlik
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.